Additive value of bioclinical risk scores to high sensitivity troponins-only strategy in acute coronary syndrome

CONCLUSION: In view of our results, the decision aids using only biological variables (hs-cTn-only strategy and CCS) would seem more effective for rule-out AMI whereas bioclinical risk scores could better identify patients at low and high risk for mortality. In consequence, risk scores taking in account comorbidities, appear necessary to determine the outcome and thus to adapt the therapeutic options. It is interesting to note that the HEART score could be useful for the rule out AMI but also for the risk prediction as confirmed by the NRI.PMID:34648808 | DOI:10.1016/j.cca.2021.10.008

Source: International Journal of Clinical Chemistry - October 14, 2021 Category: Chemistry Authors: Anne Marie Dupuy Gr égoire Pasquier Louis Thiebaut Fran çois Roubille Mustapha Sebbane Jean Paul Cristol Source Type: research